Senior Scientist I, DMPK
Company: Arrowhead Pharmaceuticals
Location: Madison
Posted on: February 17, 2026
|
|
|
Job Description:
Job Description Job Description Arrowhead Pharmaceuticals, Inc.
(Nasdaq: ARWR) is a clinical stage biopharmaceutical company that
develops medicines that treat intractable diseases by silencing the
genes that cause them. Using a broad portfolio of RNA chemistries
and efficient modes of delivery, Arrowhead therapies trigger the
RNA interference mechanism to induce rapid, deep, and durable
knockdown of target genes. RNA interference, or RNAi, is a
mechanism present in living cells that inhibits the expression of a
specific gene, thereby affecting the production of a specific
protein. Arrowhead's RNAi-based therapeutics leverage this natural
pathway of gene silencing. Arrowhead is focused on developing
innovative drugs for diseases with a genetic basis, typically
characterized by the overproduction of one or more proteins that
are involved with disease. The depth and versatility of our RNAi
technologies enables us to potentially address conditions in
virtually any therapeutic area and pursue disease targets that are
not otherwise addressable by small molecules and biologics.
Arrowhead is leading the field in bringing the promise of RNAi to
address diseases outside of the liver, and our clinical pipeline
includes disease targets in the liver and lung with a promising
pipeline of preclinical candidates. Arrowhead's corporate
headquarters is in Pasadena, CA with research and development teams
in Madison, WI & San Diego, CA, and a state of the art
manufacturing facility in Verona, WI. Our employees are nimble,
science-driven innovators who are collaborating to bring new
therapies to patients in need. The Position Arrowhead
Pharmaceuticals is seeking an accomplished Senior Scientist, DMPK
to play a key role in advancing our growing pipeline of RNAi-based
therapeutics. As a senior member of the Drug Metabolism and
Pharmacokinetics (DMPK) function, you will partner closely with
multidisciplinary teams of chemists, biologists, and translational
scientists to shape strategies that enable successful candidate
nomination and IND submissions. In this high-impact role, you will
lead the design and execution of preclinical DMPK studies, guide
interpretation of complex PK/PD data, oversee internal and external
study activities, and ensure delivery of high-quality datasets that
meet regulatory expectations. The ideal candidate brings deep
technical expertise, strong problem-solving skills, and the ability
to thrive in a fast-paced, collaborative environment dedicated to
scientific excellence and innovative drug development.
Responsibilities Develop and implement in vitro and in vivo DMPK
strategies to support preclinical development for compounds across
multiple indications and routes of administration. Manage all DMPK
activities, including oversight of internal resources and CRO
partners to ensure high-quality and timely data delivery. Design,
supervise, and execute preclinical PK studies, including
non-compartmental analysis (NCA), data interpretation, reporting,
and communication of PK/PD insights to project teams. Prepare and
deliver IND-enabling DMPK packages, ensuring compliance with
regulatory expectations and contributing to regulatory submissions.
Apply working knowledge of GLP/GCP principles and ensure
appropriate documentation for regulated studies. Support GLP
toxicokinetic (TK) study design, analysis, and reporting. Oversee
metabolite identification in preclinical and clinical samples using
high-resolution mass spectrometry (HRMS). Contribute to a dynamic,
fast-paced DMPK team by offering scientific leadership,
troubleshooting support, and cross-functional collaboration.
Maintain a current understanding of clinical pharmacology
literature and regulatory guidance for oligonucleotide/RNAi
therapeutics. Requirements PhD in Pharmacometrics, Drug Metabolism,
Pharmaceutical Sciences, or a related discipline with at least 3
years of industry experience. Deep and broad expertise in DMPK,
with working knowledge of nucleotide or oligonucleotide drug
metabolism and distribution highly desired. Hands-on experience
with in vitro ADME assays, in vivo PK studies, drug–drug
interaction (DDI) evaluations, and Phoenix WinNonlin. Experience
with LC–MS/MS and HRMS, ideally applied to oligonucleotide
therapeutics. Strong background in organic chemistry, biochemistry,
and drug biotransformation. Demonstrated experience in drug
development and understanding of regulatory processes. Excellent
interpersonal, verbal, and written communication skills, with the
ability to interpret and present complex scientific data clearly.
Wisconsin pay range $115,000—$140,000 USD Arrowhead provides
competitive salaries and an excellent benefit package. All
applicants must have authorization to work in the US for a company.
California Applicant Privacy Policy
Keywords: Arrowhead Pharmaceuticals, Janesville , Senior Scientist I, DMPK, Science, Research & Development , Madison, Wisconsin